Methadone

被引:23
作者
Chhabra, Shalini [2 ,3 ]
Bull, Janet [1 ]
机构
[1] Four Seasons Hosp & Palliat Care, Hendersonville, NC USA
[2] E Tennessee State Univ, Dept Med, Johnson City, TN 37684 USA
[3] James H Quillen Vet Affairs Med Ctr Mt Home, Home Based Primary Care, Johnson City, TN USA
关键词
pharmacodynamics; bioavailability; indications; equianalgesic dosing; methadone toxicity;
D O I
10.1177/1049909107312597
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Methadone hydrochloride is an old drug that has been in vogue off and on. It has complex pharmacodynamics and can be potentially fatal in inexperienced settings. Drug switching from an opioid to methadone or vice versa requires knowledge of equianalgesic dosing. It is critical when using the drug to monitor for signs and symptoms of toxicity so that overdosing or toxicity can be identified in a timely manner. This review discusses these important topics so that methadone can be used safely and effectively.
引用
收藏
页码:146 / 150
页数:5
相关论文
共 46 条
[1]  
ANDERSON RJ, 1981, CLIN USE DRUGS PATIE
[2]  
ANGGARD E, 1975, CLIN PHARMACOL THER, V17, P258
[3]   The rediscovery of methadone for cancer pain management [J].
Ayonrinde, OT ;
Bridge, DT .
MEDICAL JOURNAL OF AUSTRALIA, 2000, 173 (10) :536-540
[4]   Methadone blood concentrations are decreased by the administration of abacavir plus amprenavir [J].
Bart, PA ;
Rizzardi, PG ;
Gallant, S ;
Golay, KP ;
Baumann, P ;
Pantaleo, G ;
Eap, CB .
THERAPEUTIC DRUG MONITORING, 2001, 23 (05) :553-555
[5]  
BASELT RC, 1972, CLIN PHARMACOL THER, V13, P64
[6]  
BEAVER WT, 1967, CLIN PHARMACOL THER, V8, P415
[7]   BIOTRANSFORMATION OF METHADONE IN MAN - SYNTHESIS AND IDENTIFICATION OF A MAJOR METABOLITE [J].
BECKETT, AH ;
TAYLOR, JF ;
CASY, AF ;
HASSAN, MMA .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1968, 20 (10) :754-&
[8]   Distribution of R- and S-methadone into human milk during multiple, medium to high oral dosing [J].
Begg, EJ ;
Malpas, TJ ;
Hackett, LP ;
Ilett, KF .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 52 (06) :681-685
[9]  
BERKOWITZ B A, 1976, Clinical Pharmacokinetics, V1, P219, DOI 10.2165/00003088-197601030-00004
[10]  
Bruera E, 1999, ONCOLOGY-NY, V13, P1275